CUE (Cue Biopharma, Inc.) Stock Analysis

Cue Biopharma, Inc. (CUE) is a publicly traded Healthcare sector company. As of May 21, 2026, CUE trades at $20.03 with a market cap of $86.50M and a P/E ratio of -16.45. CUE moved -1.53% today. Year to date, CUE is +77.99%; over the trailing twelve months it is +1.70%. Its 52-week range spans $4.97 to $59.67. Rallies surfaces CUE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest CUE stock research?

Cue Biopharma, Inc. (CUE) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CUE moved -1.53% today.

CUE Key Metrics

Key financial metrics for CUE
MetricValue
Price$20.03
Market Cap$86.50M
P/E Ratio-16.45
EPS$-1.21
Dividend Yield0.00%
52-Week High$59.67
52-Week Low$4.97
Volume119.22K
Avg Volume0
Revenue (TTM)$32.73M
Net Income$-19.52M
Gross Margin0.00%

Latest CUE News

Recent CUE Insider Trades

  • Sarraf Pasha bought 4.23K (~$1.31K) on Dec 30, 2025.
  • Sarraf Pasha bought 77.15K (~$23.17K) on Dec 30, 2025.
  • Sarraf Pasha bought 86.95K (~$27.60K) on Dec 30, 2025.

CUE Analyst Consensus

CUE analyst coverage data. Average price target: $0.00.

Common questions about CUE

What can I research for CUE on Rallies?
Cue Biopharma, Inc. (CUE) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CUE moved -1.53% today.
Does Rallies show live market data for CUE?
Rallies combines live market context with ticker research for CUE, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
CUE

CUE